Long-Term Efficacy of Every-2-Week Dosing vs Recommended Dosing of Ixekizumab in Patients Who Had Static Physician's Global Assessment >1 at Week 12
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
An Indirect Comparison of Long-Term Efficacy of Every-2-Week Dosing vs Recommended Dosing of Ixekizumab in Patients Who Had Static Physician's Global Assessment >1 at Week 12
Br J Dermatol 2019 Sep 23;[EPub Ahead of Print], K Papp, C Maari, A Cauthen, M Gooderham, L Spelman, K Yamanaka, P Polzer, L Zhang, O Osuntokun, M AugustinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.